UBS raised the target price for RemeGen (09995) to HKD120 from HKD63.8 and upgraded the rating to "buy" from "neutral".
The research house said it is positive on the recent partnership with AbbVie.
【你點睇？】巴拿馬最高法院裁定長和港口合同違憲，港口營運暫時由丹麥馬士基接管。你認為中方以及長和會否採取措施強力反制，以維護利益？ ► 立即投票
